WuXi AppTec logo
WuXi AppTec
WUXAY | OTC
Chart Builder DCF Calculator
$23.98
-$0.34 (-1.40%)
At close: Nov 16, 2026, 3:58 PM ET
$23.98
$0.00 (0.00%)
After-hours: Nov 16, 2026, 3:58 PM ET

WuXi AppTec Company Profile

Company profile explained

Company Profile

WuXi AppTec Co., Ltd. functions as an investment holding entity, globally delivering a wide array of research, development, and manufacturing services. Operating across the People's Republic of China, other parts of Asia, the United States, and Europe, the company plays a crucial role in the discovery, advancement, and production of small molecule pharmaceuticals, as well as cell and gene therapies. The organization's operations are divided into six main segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Additional Services. It provides extensive contract research, development, and manufacturing organization (CRDMO) capabilities, supporting novel drug development from initial discovery phases through to commercial launch. This includes handling various synthetic molecular formats such as small molecules, oligonucleotides, peptides, and complex conjugates. Furthermore, WuXi AppTec offers biological services and solutions, spanning from target identification to candidate selection and progression into clinical trials, alongside integrated testing for drugs and medical devices from preclinical stages to clinical applications. The company also specializes in accelerating cell and gene therapies to market through an end-to-end solution, offers bespoke drug discovery services to pharmaceutical and biotech clients, and conducts clinical research. Founded in 2000, WuXi AppTec Co., Ltd. maintains its headquarters in Shanghai, People's Republic of China.

Key Executives

Name Position
Ge Li Co-Founder, Executive Chairman, President & Chief Executive Officer
Minzhang Chen Co-CEO & Executive Director
Qing Yang Co-CEO & Executive Director
Ming Shi Senior Vice President & Chief Financial Officer
Zhaohui Zhang Chief Operating Officer of China, Executive Vice President & Executive Director
Feng Zhang Senior Vice President of API Manufacturing
Howard Wu Senior Vice President of Legal Department & Human Resources Department
Ruijia Tang IR Director
Tao Guo Senior Vice President of RCS IPM
Youchu Wang Senior Vice President of API Early Phase Development
WuXi AppTec
WuXi AppTec logo
Country China
IPO Date Feb 24, 2021
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 33,834
CEO Ge Li

Contact Details

288 Fute Zhong Road Shanghai, SH 200131 China

Stock Details

Ticker Symbol WUXAY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 98260P103
ISIN Number US98260P1030
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.